Roivant Sciences (ROIV) Non Operating Income (2020 - 2025)

Roivant Sciences has reported Non Operating Income for 6 years, with the latest figure at $8.3 million in Q4 2025.

• For the quarter ending Q4 2025, Non Operating Income rose 396.24% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2025 stood at -$11.4 million (down 97.33% YoY), and the FY2026 full-year result was $4.0 million, up 137.42% from the prior year.
• Non Operating Income for Q4 2025 stood at $8.3 million, up from -$5.7 million in the prior quarter.
• The five-year high for Non Operating Income was $18.1 million in Q4 2022, with the low at -$11.2 million in Q2 2025.
• Historically, Non Operating Income has averaged -$182066.7 across 5 years, with a median of -$1.5 million in 2024.
• The largest YoY upside for Non Operating Income was 1658.5% in 2022 against a maximum downside of 909.7% in 2022.
• Roivant Sciences' Non Operating Income stood at $1.0 million in 2021, then jumped by 1658.5% to $18.1 million in 2022, then sank by 88.33% to $2.1 million in 2023, then slumped by 233.33% to -$2.8 million in 2024, then surged by 396.24% to $8.3 million in 2025.
• The last three Non Operating Income figures came in at $8.3 million (Q4 2025), -$5.7 million (Q3 2025), and -$11.2 million (Q2 2025), per Business Quant data.